Mara Bonelli

University of Parma — Italy

Medicine · Health Sciences

33h-index3.0kcitations92works3.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(33), PI3K/AKT/mTOR signaling in cancer(18), HER2/EGFR in Cancer Research(12), Advanced Breast Cancer Therapies(12), Genetics, Aging, and Longevity in Model Organisms(9)

Publications92 total

Correction: Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK–mTORC1 signaling
Breast Cancer Research and Treatment·2026Open Access
Correction: The anti-tumor efficacy of CDK4/6 Inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells
Journal of Experimental & Clinical Cancer Research·2025· 1 citedOpen Access
Correction: Cavazzoni et al. Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer. Cancers 2020, 12, 666
Cancers·2025Open Access
Corrigendum: CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells
Frontiers in Oncology·2024Open Access
Corrigendum to “Mesenchymal stromal cells loaded with Paclitaxel (PacliMES) a potential new therapeutic approach on mesothelioma” [Biochem. Pharmacol. 214 (2023) 115678]
Biochemical Pharmacology·2024Open Access
Myrtleciclib, a CDK4/6/9 Inhibitor for the Treatment of AggressiveCancers
Current Medicinal Chemistry·2024
Immunomodulatory effects of antiangiogenic tyrosine kinase inhibitors in renal cell carcinoma models: Impact on following anti-PD-1 treatments
Biochemical Pharmacology·2024· 9 citedOpen Access
Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines
Biochemical Pharmacology·2024· 11 citedOpen Access
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models
Scientific Reports·2024· 9 citedOpen Access
PD-L1 overexpression induces STAT signaling and promotes the secretion of pro-angiogenic cytokines in non-small cell lung cancer (NSCLC)
Lung Cancer·2023· 18 citedOpen Access
Intrinsic Resistance to Osimertinib in EGFR Mutated NSCLC Cell Lines Induced by Alteration in Cell-Cycle Regulators
Targeted Oncology·2023· 8 citedOpen Access
Mesenchymal stromal cells loaded with Paclitaxel (PacliMES) a potential new therapeutic approach on mesothelioma
Biochemical Pharmacology·2023· 7 citedOpen Access
Data from Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring <i>PIK3CA</i> Gene Alterations
2023Open Access
Data from Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring <i>PIK3CA</i> Gene Alterations
2023Open Access
Supplementary Tables S1-S5 from Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring <i>PIK3CA</i> Gene Alterations
2023Open Access
Supplementary Materials and Methods from Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring <i>PIK3CA</i> Gene Alterations
2023Open Access
Supplementary Tables S1-S5 from Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring <i>PIK3CA</i> Gene Alterations
2023Open Access
Supplementary Materials and Methods from Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring <i>PIK3CA</i> Gene Alterations
2023Open Access
Supplementary Figures S1-S5 from Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring <i>PIK3CA</i> Gene Alterations
2023Open Access
Supplementary Figures S1-S5 from Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring <i>PIK3CA</i> Gene Alterations
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Roberta Alfieri(46), Pier Giorgio Petronini(42), Claudia Fumarola(37), Andrea Cavazzoni(35), Silvia La Monica(31), Maricla Galetti(24), Marcello Tiseo(20), Daniele Cretella(19), Graziana Digiacomo(15), Andrea Ardizzoni(14), Angelo F. Borghetti(11), Federico Quaini(8), Denise Madeddu(8), Daniele Generali(7), Angela Falco(6), Kenneth P. Wheeler(6), Roberta Minari(6), Elena Galvani(6), Antonio Mutti(6), Marco Mor(6)